+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Gastritis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Gastritis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Gastric Ulcers - Epidemiology Forecast to 2032 - Product Thumbnail Image

Gastric Ulcers - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Celiac Disease (CD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Celiac Disease (CD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Opioid-Induced Constipation - Epidemiology Forecast to 2032 - Product Thumbnail Image

Opioid-Induced Constipation - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Irritable Bowel Syndrome (IBS) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Irritable Bowel Syndrome (IBS) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Peptic Ulcers - Epidemiology Forecast to 2032 - Product Thumbnail Image

Peptic Ulcers - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Traveler's Diarrhea - Epidemiology Forecast to 2032 - Product Thumbnail Image

Traveler's Diarrhea - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hemorrhoids - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hemorrhoids - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Acute Pancreatitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Acute Pancreatitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Dyspepsia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Dyspepsia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Anal Fistula - Epidemiology Forecast to 2032 - Product Thumbnail Image

Anal Fistula - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Cutaneous Ulcers - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Cutaneous Ulcers - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Oral Dysplasia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Oral Dysplasia - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Overactive Bowel Disease - Epidemiology Forecast - 2032 - Product Thumbnail Image

Overactive Bowel Disease - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Barett Esophagus - Epidemiology Forecast - 2032 - Product Thumbnail Image

Barett Esophagus - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Chronic Constipation - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Constipation - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Fecal Incontinence - Epidemiology Forecast - 2032 - Product Thumbnail Image

Fecal Incontinence - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Emesis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Emesis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Esophageal Achalasia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Esophageal Achalasia - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more